41 results
424B5
APTO
Aptose Biosciences Inc
3 Jun 24
Prospectus supplement for primary offering
6:05am
;
additions or departures of key personnel;
health care reform legislation, including measures directed at controlling the pricing of pharmaceutical products
8-K
EX-10.1
APTO
Aptose Biosciences Inc
1 May 24
Entry into a Material Definitive Agreement
4:30pm
anticipates such benefit programs will include: group health care coverage (including medical, dental and vision), life insurance, short term and long term … ”). Until the Corporation adopts and establishes a group health care coverage plan, the Corporation agrees to pay Executive a taxable monthly benefits
424B4
APTO
Aptose Biosciences Inc
26 Jan 24
Prospectus supplement with pricing info
5:30pm
have established, comply with federal, state and provincial health-care fraud and abuse laws and regulations, report financial information or data … , the Patient Protection and Affordable Care Act, as amended by the Health Care Education Reconciliation Act, or collectively the Affordable Care Act
8-K
EX-10.1
m5zm xu25m5wv
12 Dec 22
Entry into a Material Definitive Agreement
8:00am
8-K
EX-1.1
b500uw
16 Jul 20
Aptose Announces Pricing of Public Offering of Common Shares
4:05pm
8-K
EX-10.1
pwhr 0n2kvs
5 May 20
Aptose Reports Results for the First Quarter 2020
5:01pm
8-K
EX-1.1
na38qjh3fx8
17 Dec 19
Aptose Announces Pricing of Public Offering of Common Shares
2:27pm
8-K
EX-1.1
tank4w26qp6k
30 May 19
Aptose Announces Pricing of Public Offering of Common Shares
4:13pm
8-K
EX-10.1
qr21eccpt3f7y
24 May 19
Entry into a Material Definitive Agreement
5:20pm
10-Q
qs8on 2ws8tduf7o
7 May 19
Quarterly report
4:47pm
10-K
2exh92
12 Mar 19
Annual report
4:57pm
6-K
EX-99.1
tfan0 1md
20 Nov 18
Aptose to Participate in Upcoming Investor Conferences, Host Key Opinion Leader Event, and Present Data at the Upcoming ASH Meeting
7:05am
6-K
EX-99.2
o6337p91wzlf23qy
22 Jun 18
Current report (foreign)
2:03pm
6-K
EX-99.1
hk7h79x1ewmv7
9 May 18
Current report (foreign)
12:20pm